- Recent Funding
- Investors
- Max Lugavere
Max Lugavere portfolio
Max Lugavere has 1 portfolio company on record at Recent Funding.
About this page
It is an angel investor. Its most recent investment on record is Slate Milk's $23M Series B+ round in September 2025, alongside Peter Rahal, Will Levis, RiverPark Ventures and 6 others. That company is in Health and bio.
What Max Lugavere invests in
- Health and bio · 1 · 100%
- Commerce and retail · 1 · 100%
- Consumer and social · 1 · 100%
How Max Lugavere invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $23M |
Max Lugavere portfolio companies
SSlate Milk$23MSeries B+ · Sep 2025
| Company | Round with Max Lugavere | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $23M | $35.2M | Sep 18, 2025 Series B+ |
Most frequent co-investors
RRiverPark Ventures1 shared round · last Sep 18, 2025
RRyan Tedder1 shared round · last Sep 18, 2025
PPeter Rahal1 shared round · last Sep 18, 2025
- WWill Levis1 shared round · last Sep 18, 2025
- MMike Gesicki1 shared round · last Sep 18, 2025
- MMike Gagent1 shared round · last Sep 18, 2025
SShawn Johnson1 shared round · last Sep 18, 2025
- TThomas Wesley Pentz1 shared round · last Sep 18, 2025
MMaxx Robert Crosby1 shared round · last Sep 18, 2025
Similar investors
RRishubh Satiya2 companies · 1 deal in 12 mo
AArjun Vaidya7 companies · 3 deals in 12 mo
AArjun Purkayastha8 companies · 4 deals in 12 mo
RRoman Saini8 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Max Lugavere. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Max Lugavere, which is a subset of its real portfolio. API: /api/v1/investors/max-lugavere (get a free API key). More: the most active VC firms and new venture capital funds.